KRAS and colorectal carcinoma: To gain some insight into the molecular mechanisms underlying the KRAS‐dependent effects of TIMP‐1 in CRC, we examined a matched pair of isogenic human CRC DLD‐1 cell line clones (KRAS G13D and wild‐type) exposed, or not, to TIMP‐1.